EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients

Jing Guo iD, Zhenfeng Hu, Liang Ren iD, Weibo Zhao, Ruijing Zuo, Shuang Guo, Chaoguo Jia, Wei Gao

Journal of Clinical Laboratory Analysis · 2023

DOI: 10.1002/jcla.24853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Jing Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, HanDan Central Hospital, Handan, China. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Research and Development Program of HanDan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory cytokines are implicated in the development of atherosclerosis and cardiomyocyte injury during acute myocardial infarction (AMI). This study aimed to investigate the correlation of eight common inflammatory cytokines with major adverse cardiac event (MACE) risk and further establish a prognostic model in AMI patients.

Methods

Serum samples of 210 AMI patients and 20 angina pectoris patients were, respectively, collected at admission, to detect tumor necrosis factor‐alpha (TNF‐α), interleukin (IL)‐1β, IL‐6, IL‐8, IL‐10, IL‐17A, vascular cell adhesion molecule‐1 (VCAM‐1), and intercellular adhesion molecule 1 (ICAM‐1) via enzyme‐linked immunosorbent assay.

Results

TNF‐α, IL‐6, IL‐8, IL‐17A, VCAM‐1, and ICAM‐1 were elevated (all p < 0.050); IL‐10 ( p = 0.009) was declined; IL‐1β ( p = 0.086) was not varied in AMI patients compared with angina pectoris patients. TNF‐α ( p = 0.008), IL‐17A ( p = 0.003), and VCAM‐1 ( p = 0.014) were elevated in patients with MACE occurrence compared to patients without MACE occurrence; meanwhile, they possessed a relatively good value for identifying MACE risk via receiver‐operating characteristic (ROC) analysis. Subsequent multivariate logistic regression analysis revealed that the independent risk factors for MACE contained TNF‐α (odds ratio (OR) = 1.038, p < 0.001), IL‐1β (OR = 1.705, p = 0.044), IL‐17A (OR = 1.021, p = 0.009), history of diabetes mellitus (OR = 4.188, p = 0.013), history of coronary heart disease (OR = 3.287, p = 0.042), and symptom‐to‐balloon time (OR = 1.064, p = 0.030), whose combination disclosed a satisfying prognostic value for MACE risk (area under the curve: 0.877, 95% CI: 0.817–0.936).

Conclusion

Elevated levels of serum TNF‐α, IL‐1β, and IL‐17A independently correlated with MACE risk in AMI patients, which perhaps provide novel auxiliary for AMI prognostic prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaMyocardial InfarctionHumansInterleukin-10Interleukin-1betaIntercellular Adhesion Molecule-1Interleukin-17Interleukin-6Interleukin-8Vascular Cell Adhesion Molecule-1CytokinesAngina Pectoris

Stichwörter der Autor:innen

acute myocardial infarctionbiomarkerinflammatory cytokinesmajor adverse cardiac eventprognostic value

Substanzen

Tumor Necrosis Factor-alphaInterleukin-10Interleukin-1betaIntercellular Adhesion Molecule-1Interleukin-17Interleukin-6Interleukin-8Vascular Cell Adhesion Molecule-1Cytokines

Autor:innen und Institutionen

  • Department of Cardiology, HanDan Central Hospital, Handan, China.
  • Department of General Surgery (Department of Plastic Surgery), Affiliated Hospital of Hebei University of Engineering, Handan, China.
  • Emergency Department, Handan Central Hospital, Handan, China.

ORCID-Profile: Jing Guo, Liang Ren

Förderung

  • Science and Technology Research and Development Program of HanDan

Zitieren

APA

Guo, J., Hu, Z., Ren, L., Zhao, W., Zuo, R., Guo, S., Jia, C., & Gao, W. (2023). Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24853

Vancouver

Guo J, Hu Z, Ren L, Zhao W, Zuo R, Guo S, et al. Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24853

BibTeX
@article{Guo2023,
  author = {Guo, Jing and Hu, Zhenfeng and Ren, Liang and Zhao, Weibo and Zuo, Ruijing and Guo, Shuang and Jia, Chaoguo and Gao, Wei},
  title = {Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2023},
  doi = {10.1002/jcla.24853}
}
Kostenlos starten →